Exact Sciences test may let more breast cancer patients skip chemo
With help from a test from Madison-based Exact Sciences, tens of thousands more breast cancer patients may be able to safely forgo chemotherapy, according to a study published this month in the New England Journal of Medicine. The study, called RxPONDER, was led by the...